Panel on Multidistrict Litigation (JPML) heard arguments to consider consolidating all federally filed Zantac lawsuits before one court. Both plaintiffs and defendants agreed that consolidation was prudent given the shared questions of fact, but they disagreed on the preferred location for the MDL.
In October 2019, Johnson & Johnson (J&J) issued a voluntary recall of a single lot of its Baby Powder. The Food and Drug Administration (FDA), when testing one sample of that Baby Powder, had discovered sub-trace levels of asbestos, so J&J implemented the recall out…
About a year ago, on February 14, 2019, New York Governor Cuomo signed the New York Child Victims Act into law. It extended the deadline for filing civil lawsuits against child sexual abusers and private or public institutions until a survivor’s 55th birthday. Before that,…
The Food and Drug Administration (FDA) recently announced a recall of three lots of Mylan nizatidine capsules because tests indicated the presence of trace amounts of N-nitrosodimethylamine (NDMA). NDMA has been classified as a probable human carcinogen and is the same chemical that has recently…
Over the last several months, e-cigarette manufacturer JUUL has faced increasing scrutiny and pressure from the U.S. government, the FDA, and the courts for its connection to the epidemic of vaping among America’s youth. The FDA has sent the company warning letters over its marketing…
In September 2019, the U.S. Food and Drug Administration (FDA) warned healthcare providers and patients that ranitidine drugs, including brand-name Zantac, had been found to contain N-nitrosodimethylamine (NDMA), a probable human carcinogen. The warning sent ripples through the healthcare community,
According to a new report from the U.S. Consumer Product Safety Commission (CPSC), fewer children are suffering injuries related to their toys. Between 2014 and 2018, there was a decline in the number of injuries associated with all toys, which is good news. The bad…
On December 18, 2019, the Food and Drug Administration (FDA) announced yet another generic ranitidine recall, this time implemented by Glenmark Pharmaceutical Inc. The company is pulling all prescription ranitidine tablets (150 mg and 300 mg) from the U.S. market because they may contain unacceptab
The Food and Drug Administration (FDA) recently released new guidelines meant to help increase the safety of vaping products. A 2017 report released by the U.S. Fire Administration showed that between January 2009 and December 31, 2016, there were 195 separate incidents of explosion and…
On November 4, 2019, plaintiffs involved in Zantac lawsuits filed a motion with the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate all federally filed Zantac lawsuits into one federal court for more efficient pre-trial proceedings. Consolidation will help preserve resources a
As JUUL Labs struggles under increasing pressure and investigations over its marketing of its e-cigarettes to minors, one of its major investors—Altria—now faces a new class-action lawsuit filed by plaintiffs who claim the company misled its investors when buying a stake in the manufacturing company
On November 14, 2019, the U.S. National Highway Traffic Safety Administration (NHTSA) acknowledged a safety recall implemented by Nissan North America. The company is recalling nearly 400,000 vehicles due to a potential issue in the vehicles’ antilock brake system. This is the third recall related…
